United Therapeutics Corporation UTHR

Set alert

608.49 USD +7.17 (+1.19%)

At closeNov 5, 2026, 4:00 AM EST

612.99 +4.50 +0.74%

Pre-market · Nov 5, 4:00 AM ET

578.28 Day range 614.23

432.53 52-week range 614.23

Held by insiders 2.00%

Held by institutions 100.33%

Float held by institutions 102.38%

Institutions 1,224

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	12.34%	5,294,529	3.22B	Jun 29, 2026
Avoro Capital Advisors LLC	6.48%	2,777,777	1.69B	Jun 29, 2026
Vanguard Portfolio Management LLC	4.48%	1,919,429	1.17B	Jun 29, 2026
Vanguard Capital Management LLC	4.47%	1,918,256	1.17B	Jun 29, 2026
State Street Corporation	4.43%	1,898,064	1.15B	Jun 29, 2026
Renaissance Technologies, LLC	3.98%	1,708,739	1.04B	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
iShares Trust-iShares Core S&P Mid-Cap ETF	3.56%	1,527,799	929.65M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	3.14%	1,347,720	820.07M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	2.27%	973,490	592.36M	Jun 29, 2026
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund	1.68%	719,385	437.74M	Jul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	1.13%	486,555	296.06M	Jun 29, 2026
iShares Trust-iShares Biotechnology ETF	0.75%	323,432	196.81M	Sep 29, 2026

UTHR insiders
Insider	Relation	Latest transaction	Date	Shares held
BENKOWITZ MICHAEL	President	Conversion of Exercise of derivative security	Mar 12, 2026	0
CAUSEY CHRISTOPHER	Director	Sale	Mar 29, 2026	4,190
EDGEMOND JAMES C.	Chief Financial Officer	Sale	Jun 21, 2026	18,876
GILTNER RICHARD A	Director	Conversion of Exercise of derivative security	Jul 8, 2026	21,884
KURZWEIL RAYMOND C	Director	Conversion of Exercise of derivative security	Jul 8, 2026	13,320
MAHON PAUL A	General Counsel	Sale	Sep 30, 2026	45,172

Held by funds